My watch list
my.bionity.com  
Login  

FLEA (psychedelic)



FLEA (psychedelic)
Systematic (IUPAC) name
N-(2-Benzo[1,3]dioxol-5-yl-1-methyl-ethyl)-N-methyl-hydroxylamine
Identifiers
CAS number 214414-88-7
ATC code  ?
PubChem  ?
Chemical data
Formula C11H15NO3 
Mol. mass 209.24
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

FLEA, or 3,4-methylenedioxy-alpha,N-dimethyl-N-hydroxyphenethylamine, is a lesser-known psychedelic drug and a substituted Amphetamine. It is the N-hydroxy homolog of MDMA (Ecstasy). FLEA was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage range is listed as 100-160 mg, and the duration listed as 4-8.[1] FLEA causes entactogenic, open MDMA-like effects and eases communication. It also increases appreciation of the senses. Very little data exists about the pharmacological properties, metabolism, and toxicity of FLEA.

References

  1. ^ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. 
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "FLEA_(psychedelic)". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE